Curebase

Active

Modern, AI-powered clinical trial software platform.

What it does

Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC.

Its site says now · captured 2026-08-23

eClinical Platform - ePRO/eCOA, eConsent, EDC, Recruitment | Clinical Trial Technology Platform | Curebase

Launch studies faster, improve data quality, and keep patients engaged, with modern ePRO, eConsent, participant recruitment, EDC, and site software.

Next to it in Healthcare and bio · AI-powered clinical trial software

  • BiorcePlug and Play

    Revolutionizing drug development through the power of AI.

  • Perceiv AIPlug and Play

    AI-driven precision medicine for clinical trials

  • Massive Bio500 Global

    Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.

  • AppliedVRTechstars TS 2016

    AppliedVR

  • AcclinateTechstars TS 2021

    Acclinate | Clinical Trial Diversity & Health Equity

  • MedMe HealthY Combinator W21

    Software for pharmacies to move beyond dispensing

  • Elligo Health ResearchPlug and Play

    Elligo Health Research accelerates clinical trials through EHR data, our proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems.

  • Infiuss HealthPlug and Play

    Bringing global clinical Research and clinical trials direct-to-African participants